News & Updates

Show Multimedia Only
Modified-dose nirmatrelvir-ritonavir well tolerated, effective in advanced CKD patients Modified-dose nirmatrelvir-ritonavir well tolerated, effective in advanced CKD patients

Modified-dose nirmatrelvir-ritonavir well tolerated, effective in advanced CKD patients

15 Aug 2023 byChristina Lau

Modified-dose regimens of nirmatrelvir-ritonavir are well tolerated and effective in COVID-19 patients with advanced chronic kidney disease (CKD), including those on dialysis, a study by the Chinese University of Hong Kong (CUHK) has shown.

15 Aug 2023
Metabolic syndrome carries increased risk of lung cancer

Metabolic syndrome carries increased risk of lung cancer

15 Aug 2023

Individuals with metabolic syndrome (MetS) have a heightened risk of incident lung cancer, with the risk increase especially pronounced in those with a higher number of metabolic abnormalities and in women, according to a study.

15 Aug 2023
Nutritional status predicts treatment tolerability, mortality risk in IPF patients

Nutritional status predicts treatment tolerability, mortality risk in IPF patients

10 Aug 2023

The nutritional status of patients with idiopathic pulmonary fibrosis (IPF) has a significant impact on both treatment and outcome, suggests a study, noting that assessing the nutritional status offers helpful information for managing these individuals.

10 Aug 2023